T1	p 124 141	type 1 diabetes .
T2	p 562 633	24 patients , 8-18 years old , with newly diagnosed T1D . Subjects were
T3	i 6 26	Insulin pump therapy
T4	i 320 340	insulin pump therapy
T5	i 485 496	MDI therapy
T6	i 502 556	continuous subcutaneous insulin therapy ( pump therapy
T7	i 943 950	glucose
T8	i 1614 1626	insulin pump
T9	o 73 81	glycemic
T10	o 183 218	residual insulin secretory capacity
T11	o 725 816	Preservation of insulin secretion , measured by mixed-meal-stimulated C-peptide secretion ,
T12	o 896 1050	glycosylated hemoglobin ( HbA1c ) , continuous glucose sensor data , insulin utilization , anthropometric measures , and patient satisfaction with therapy
T13	o 1184 1244	higher mixed-meal tolerance test-stimulated C-peptide values
T14	o 1353 1369	glycemic control
T15	o 1428 1433	spent
T16	o 1439 1452	normoglycemia
T17	o 1534 1546	satisfaction
T18	o 1657 1665	glycemic
T19	o 1685 1694	tolerated
T20	o 1725 1745	patient satisfaction